Qa-2 expression levels is related with tumor-infiltrating lymphocytes profile during solid Ehrlich tumor development

Delort, 2015, Leptin, adipocytes and breast cancer: focus on inflammation and anti-tumor immunity, Life Sci., 140, 37, 10.1016/j.lfs.2015.04.012 Engels, 2015, The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysis, Breast Cancer Res. Treat., 149, 587, 10.1007/s10549-015-3269-7 Romo-Gonzalez, 2015, The network of antigen-antibody reactions in adult women with breast cancer or benign breast pathology or without breast pathology, PLoS One, 10, e0119014, 10.1371/journal.pone.0119014 Agaugue, 2011, Role of HLA-G in tumor escape through expansion of myeloid-derived suppressor cells and cytokinic balance in favor of Th2 versus Th1/Th17, Blood, 117, 7021, 10.1182/blood-2010-07-294389 Matkowski, 2009, The prognostic role of tumor-infiltrating CD4 and CD8T lymphocytes in breast cancer, Anticancer Res., 29, 2445 Sato, 2005, Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer, Proc. Natl. Acad. Sci. U. S. A., 102, 18538, 10.1073/pnas.0509182102 Mittal, 2014, New insights into cancer immunoediting and its three component phases–elimination, equilibrium and escape, Curr. Opin. Immunol., 27, 16, 10.1016/j.coi.2014.01.004 Dushyanthen, 2015, Relevance of tumor-infiltrating lymphocytes in breast cancer, BMC Med., 13, 202, 10.1186/s12916-015-0431-3 Wesolowski, 2014, Tumor infiltrating lymphocytes – the next step in assessing outcome and response to treatment in patients with breast cancer, J. Carcinog. Mutagen., 5 Cimino-Mathews, 2015, Immune targeting in breast cancer, Oncology (Williston Park), 29, 375 Tung, 2015, Tumor-infiltrating lymphocytes and response to platinum in triple-negative breast cancer, J. Clin. Oncol., 33, 969, 10.1200/JCO.2014.59.6031 Mao, 2014, The value of tumor infiltrating lymphocytes (TILs) for predicting response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis, PLoS One, 9, e115103, 10.1371/journal.pone.0115103 Curigliano, 2013, Molecular pathways: human leukocyte antigen G (HLA-G), Clin. Cancer Res., 19, 5564, 10.1158/1078-0432.CCR-12-3697 Carosella, 2015, HLA-G: an immune checkpoint molecule, Adv. Immunol., 127, 33, 10.1016/bs.ai.2015.04.001 Richmond, 2008, Mouse xenograft models vs GEM models for human cancer therapeutics, Dis. Models Mech., 1, 78, 10.1242/dmm.000976 Cao, 1999, Search for a human homologue of the mouse Ped gene, Mol. Hum. Reprod., 5, 541, 10.1093/molehr/5.6.541 Lee, 2010, The role of Qa-2, the functional homolog of HLA-G, in a Behcet's disease-like mouse model induced by the herpes virus simplex, J. Inflamm. (Lond.), 7, 31, 10.1186/1476-9255-7-31 Comiskey, 2003, Evidence that HLA-G is the functional homolog of mouse Qa-2, the Ped gene product, Hum. Immunol., 64, 999, 10.1016/j.humimm.2003.08.352 Chiang, 2002, The nonclassical major histocompatibility complex molecule Qa-2 protects tumor cells from NK cell- and lymphokine-activated killer cell-mediated cytolysis, J. Immunol., 168, 2200, 10.4049/jimmunol.168.5.2200 Chiang, 2004, A nonclassical MHC class I molecule restricts CTL-mediated rejection of a syngeneic melanoma tumor, J. Immunol., 173, 4394, 10.4049/jimmunol.173.7.4394 Ungchusri, 2001, Widespread expression of the nonclassical class I Qa-2 antigens in hemopoietic and nonhemopoietic cells, Immunogenetics, 53, 455, 10.1007/s002510100347 Li, 2012, Qa-2 associated lipid rafts are indispensable in the final maturation of CD4(+)CD8(−) thymocytes, Immunol. Lett., 148, 163, 10.1016/j.imlet.2012.10.006 Hogarth, 1985, The distribution of the Qa-2 alloantigen on functional T lymphocytes, J. Immunol., 135, 1632, 10.4049/jimmunol.135.3.1632 De Fazio, 2007, Activation of T cells by cross-linking Qa-2, the ped gene product, requires Fyn, Am. J. Reprod. Immunol., 58, 315, 10.1111/j.1600-0897.2007.00503.x Hahn, 1989, Anti-Qa-2-induced T cell activation. The parameters of activation, the definition of mitogenic and nonmitogenic antibodies, and the differential effects on CD4+ vs CD8+ T cells, J. Immunol., 143, 407, 10.4049/jimmunol.143.2.407 Cook, 1992, Characterization of T cell proliferative responses induced by anti-Qa-2 monoclonal antibodies, Cell. Immunol., 144, 367, 10.1016/0008-8749(92)90252-K He, 2001, Promiscuous antigen presentation by the nonclassical MHC Ib Qa-2 is enabled by a shallow, hydrophobic groove and self-stabilized peptide conformation, Structure, 9, 1213, 10.1016/S0969-2126(01)00689-X Kabel, 2015, Effect of metformin and adriamycin on transplantable tumor model, Tissue Cell, 47, 498, 10.1016/j.tice.2015.07.003 Ferreira, 2007, Ehrlich tumor as model to study artificial hyperthyroidism influence on breast cancer, Pathol. Res. Pract., 203, 39, 10.1016/j.prp.2006.09.005 Dong, 2010, Human leukocyte antigen-G (HLA-G) expression in cervical lesions: association with cancer progression, HPV 16/18 infection, and host immune response, Reprod. Sci., 17, 718, 10.1177/1933719110369183 Loumagne, 2014, In vivo evidence that secretion of HLA-G by immunogenic tumor cells allows their evasion from immunosurveillance, Int. J. Cancer, 135, 2107, 10.1002/ijc.28845 Liu, 2010, Tumor initiation via loss of cell contact inhibition versus Ras mutation: do all roads lead to EMT?, ABBV Cell Cycle, 9, 897, 10.4161/cc.9.5.10933 Park, 2004, Soluble HLA-G generated by proteolytic shedding inhibits NK-mediated cell lysis, Biochem. Biophys. Res. Commun., 313, 606, 10.1016/j.bbrc.2003.11.153 Rizzo, 2013, Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding, Mol. Cell. Biochem., 381, 243, 10.1007/s11010-013-1708-5 Marshall, 2016, Emerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasis, Mol. Cancer, 15, 67, 10.1186/s12943-016-0551-1